<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">MISOPROSTOL</span><br/>(my-so-prost'ole)<br/><span class="topboxtradename">Cytotec<br/></span><b>Classifications:</b> <span class="classification">prostaglandin</span><br/><b>Prototype: </b>Dinoprostone<br/><b>Pregnancy Category: </b>X<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>100 mcg, 200 mcg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Synthetic prostaglandin E<sub>1</sub> analog, with both antisecretory (inhibiting gastric acid secretion) and mucosal protective properties. Increases bicarbonate
         and mucosal protective properties. Also increases bicarbonate and mucous production.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Inhibits basal and nocturnal gastric acid secretion and acid secretion in response to a variety of stimuli, including meals,
         histamine, pentagastrin, and coffee. Produces uterine contractions that may endanger pregnancy and cause a miscarriage.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Prevention of NSAID (including aspirin-induced) gastric ulcers in patients at high risk of complications from a gastric ulcer
         (e.g., the older adult and patients with a concomitant debilitating disease or a history of ulcers). Drug is taken for the
         duration of NSAID therapy and does not interfere with the efficacy of the NSAID.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Short-term treatment of duodenal ulcers; cervical ripening and induction of labor.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>History of allergies to prostaglandins; pregnancy (category X), lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Renal impairment. Safety in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Prevention of NSAID-Induced Ulcers</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 100200 mcg q.i.d. p.c. and h.s. or 200 mcg b.i.d. or t.i.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with food to minimize GI adverse effects (manufacturer recommendation).</li>
<li>Store away from heat, light, and moisture.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Headache. <span class="typehead">GI:</span>
<span class="speceff-common">Diarrhea, abdominal pain,</span> nausea, flatulence, dyspepsia, vomiting, constipation. <span class="typehead">Urogenital:</span> Spotting, cramps, dysmenorrhea, uterine contractions. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<span class="classification">magnesium-containing antacids</span> may increase diarrhea. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract; extensive first pass metabolism. <span class="typehead">Onset:</span> 30 min. <span class="typehead">Peak:</span> 6090 min. <span class="typehead">Duration:</span> At least 3 h. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Primarily excreted in urine; small amount excreted in feces. <span class="typehead">Half-Life:</span> 2040 min. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for diarrhea; may be minimized by giving drug after meals and at bedtime. Diarrhea is a common adverse effect that
            is dose related and usually self-limiting (often resolving in 8 d).
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Avoid using concurrent magnesium-containing antacids because of increased incidence of diarrhea.</li>
<li>Report postmenopausal bleeding to physician; it may be drug related.</li>
<li>Avoid pregnancy during misoprostol therapy; use an effective contraception method while taking drug.</li>
<li>Drug has abortifacient property. Contact physician and immediately discontinue drug if you becomes pregnant.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>